Cargando…
Development of Hip Bone Geometry During Gender‐Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty
Bone geometry can be described in terms of periosteal and endocortical growth and is partly determined by sex steroids. Periosteal and endocortical apposition are thought to be regulated by testosterone and estrogen, respectively. Gender‐affirming hormone (GAH) treatment with sex steroids in transge...
Autores principales: | van der Loos, Maria ATC, Hellinga, Ilse, Vlot, Mariska C, Klink, Daniel T, den Heijer, Martin, Wiepjes, Chantal M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247856/ https://www.ncbi.nlm.nih.gov/pubmed/33507568 http://dx.doi.org/10.1002/jbmr.4262 |
Ejemplares similares
-
Development of Hip Bone Geometry in Transgender Adolescents Resembles the Experienced Gender if GnRHa Treatment Is Started in Early, but Not Late, Puberty
por: van der Loos, Maria A T C, et al.
Publicado: (2021) -
Gender‐Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen
por: Vlot, Mariska C, et al.
Publicado: (2019) -
SAT416 The Incidence Of Autoimmune Disease In Transgender People After Initiation Of Gender-Affirming Hormone Therapy
por: Wiepjes, Chantal, et al.
Publicado: (2023) -
Bone Safety During the First Ten Years of Gender‐Affirming Hormonal Treatment in Transwomen and Transmen
por: Wiepjes, Chantal M, et al.
Publicado: (2018) -
SAT398 Pubertal Status And Trends In Gender Affirming Treatment Of Transgender And Gender Diverse Youth
por: Lin, Cathy, et al.
Publicado: (2023)